AngioDynamics, Inc. (ANGO)Healthcare | Medical Instruments & Supplies | Latham, United States | NasdaqGS
10.72 USD
-0.07
(-0.649%) ⇩
(April 21, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | April 19, 2026, 12:12 a.m. EDT
AngioDynamics (ANGO) presents a classic 'contrarian bull' setup but is fundamentally broken for the impatient investor. While analysts are strong buyers and technicals hint at a trend reversal after a 5.8% drop, the company is earning negative operating income and has no dividend. The gap between the 'Strong Buy' analyst consensus (Target $18) and the deteriorating gross margins creates a trap. The high IV suggests the market is pricing in volatility, not certainty. Unless the margin compression resolves quickly, the short-term 'reversal' trades may fail, making this a hold-to-conviction-buy only for multi-year timelines, not a quick pulse. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.049466 |
| MSTL | 0.055940 |
| AutoETS | 0.056922 |
| AutoARIMA | 0.057442 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.90 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.433 |
| Excess Kurtosis | -0.68 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 6.573 |
| Revenue per Share | 7.588 |
| Market Cap | 442,938,784 |
| Forward P/E | -48.73 |
| Beta | 0.44 |
| Profit Margins | -10.01% |
| Website | https://www.angiodynamics.com |
As of April 19, 2026, 12:12 a.m. EDT: Near-term options activity (Apr 17) shows extremely high Implied Volatility (IV ~1.3-1.5) relative to longer-dated expirations, suggesting elevated local volatility expectations following recent earnings. Options positioning is heavy on 'Top OI' strikes above current price (e.g., $12.50 and $20.00 calls, $12.50 puts). This distribution indicates a significant 'straddle' or 'strangle' hedge setup by speculators betting on a sharp move in either direction, rather than a clear directional bias. The heavy put positioning at $12.50 for May 15 aligns with the news of gross margin declines and lowered analyst targets, while heavy call positioning at higher strikes suggests a pent-up demand thesis for a potential trend reversal.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.14652407 |
| Address1 | 14 Plaza Drive |
| All Time High | 32.0 |
| All Time Low | 5.26 |
| Ask | 13.69 |
| Ask Size | 2 |
| Audit Risk | 7 |
| Average Daily Volume10 Day | 489,850 |
| Average Daily Volume3 Month | 442,744 |
| Average Volume | 442,744 |
| Average Volume10Days | 489,850 |
| Beta | 0.435 |
| Bid | 7.77 |
| Bid Size | 2 |
| Board Risk | 2 |
| Book Value | 4.159 |
| City | Latham |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 3 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 10.72 |
| Current Ratio | 2.354 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 10.91 |
| Day Low | 10.645 |
| Debt To Equity | 6.573 |
| Display Name | AngioDynamics |
| Earnings Call Timestamp End | 1,775,131,200 |
| Earnings Call Timestamp Start | 1,775,131,200 |
| Earnings Timestamp | 1,775,133,000 |
| Earnings Timestamp End | 1,775,133,000 |
| Earnings Timestamp Start | 1,775,133,000 |
| Ebitda | -659,000 |
| Ebitda Margins | -0.0021 |
| Enterprise To Ebitda | -637.961 |
| Enterprise To Revenue | 1.34 |
| Enterprise Value | 420,416,064 |
| Eps Current Year | -0.20333 |
| Eps Forward | -0.22 |
| Eps Trailing Twelve Months | -0.76 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 10.8316 |
| Fifty Day Average Change | -0.11159992 |
| Fifty Day Average Change Percent | -0.01030318 |
| Fifty Two Week Change Percent | 14.652407 |
| Fifty Two Week High | 13.99 |
| Fifty Two Week High Change | -3.2699995 |
| Fifty Two Week High Change Percent | -0.23373835 |
| Fifty Two Week Low | 8.36 |
| Fifty Two Week Low Change | 2.3600006 |
| Fifty Two Week Low Change Percent | 0.28229675 |
| Fifty Two Week Range | 8.36 - 13.99 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,086,096,600,000 |
| Float Shares | 34,955,023 |
| Forward Eps | -0.22 |
| Forward P E | -48.727276 |
| Free Cashflow | 13,942,250 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 675 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.54295 |
| Gross Profits | 170,336,992 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.1228 |
| Held Percent Institutions | 0.95829004 |
| Implied Shares Outstanding | 41,318,915 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,748,649,600 |
| Long Business Summary | AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York. |
| Long Name | AngioDynamics, Inc. |
| Market | us_market |
| Market Cap | 442,938,784 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_4803544 |
| Most Recent Quarter | 1,772,236,800 |
| Net Income To Common | -31,387,000 |
| Next Fiscal Year End | 1,780,185,600 |
| Non Diluted Market Cap | 443,351,957 |
| Number Of Analyst Opinions | 4 |
| Open | 10.79 |
| Operating Cashflow | 4,448,000 |
| Operating Margins | -0.08198 |
| Overall Risk | 3 |
| Payout Ratio | 0.0 |
| Peg Ratio | 1.41 |
| Phone | 518 795 1400 |
| Previous Close | 10.79 |
| Price Eps Current Year | -52.72218 |
| Price Hint | 2 |
| Price To Book | 2.5775428 |
| Price To Sales Trailing12 Months | 1.4118696 |
| Profit Margins | -0.10005 |
| Quick Ratio | 1.262 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0699997 |
| Regular Market Change Percent | -0.648746 |
| Regular Market Day High | 10.91 |
| Regular Market Day Low | 10.645 |
| Regular Market Day Range | 10.645 - 10.91 |
| Regular Market Open | 10.79 |
| Regular Market Previous Close | 10.79 |
| Regular Market Price | 10.72 |
| Regular Market Time | 1,776,801,601 |
| Regular Market Volume | 314,989 |
| Return On Assets | -0.04681 |
| Return On Equity | -0.17475 |
| Revenue Growth | 0.089 |
| Revenue Per Share | 7.588 |
| Sand P52 Week Change | 0.3140242 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 6 |
| Shares Outstanding | 41,318,915 |
| Shares Percent Shares Out | 0.044099998 |
| Shares Short | 1,821,431 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 2,176,310 |
| Short Name | AngioDynamics, Inc. |
| Short Percent Of Float | 0.0469 |
| Short Ratio | 5.09 |
| Source Interval | 15 |
| State | NY |
| Symbol | ANGO |
| Target High Price | 24.0 |
| Target Low Price | 16.0 |
| Target Mean Price | 18.0 |
| Target Median Price | 16.0 |
| Total Cash | 37,810,000 |
| Total Cash Per Share | 0.907 |
| Total Debt | 11,394,000 |
| Total Revenue | 313,724,992 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.76 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 10.9295 |
| Two Hundred Day Average Change | -0.20949936 |
| Two Hundred Day Average Change Percent | -0.019168248 |
| Type Disp | Equity |
| Volume | 314,989 |
| Website | https://www.angiodynamics.com |
| Zip | 12,110 |